002773 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Chengdu Kanghong Pharmaceutical Group Co., Ltd. engages in the research, development, production and sale of Chinese patent medicines, chemical medicines and biological products. Its products include Conbercept Ophthalmic Injection, Shugan Jieyu Jiaonang, Ganke Shuangqing Jiaonang, Yiqing Jiaonang, Venlafaxine Hydrochloride Capsules, Xuan Maigangu, Aripiprazole, Keluoxin, Danshu Jiaonang, Mosapride Citrate, and Dexzopiclone. The company was founded on October 3, 1996 and is headquartered in Chengdu, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
002773 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company